Previous Close | $7.97 |
Intrinsic Value | $0.00 |
Upside potential | -100% |
Data is not available at this time.
Owens & Minor, Inc. operates as a global healthcare logistics company specializing in distribution, supply chain management, and clinical solutions. The company serves hospitals, integrated delivery networks, and other healthcare providers, offering medical-surgical products, pharmaceuticals, and supply chain technology. Its revenue model is driven by bulk distribution, direct-to-provider logistics, and value-added services such as inventory management and procurement optimization. Owens & Minor holds a strong position in the healthcare supply chain sector, leveraging its extensive distribution network and technological capabilities to differentiate itself from competitors. The company operates in a highly fragmented but essential industry, where efficiency and reliability are critical. Its market positioning is reinforced by long-term contracts with healthcare providers and manufacturers, providing stable revenue streams. However, the sector faces margin pressures due to regulatory changes and competitive pricing dynamics, requiring continuous operational improvements.
Owens & Minor reported revenue of $10.7 billion for FY 2024, reflecting its scale in healthcare distribution. However, the company posted a net loss of $362.7 million, with diluted EPS of -$4.73, indicating profitability challenges. Operating cash flow stood at $161.5 million, while capital expenditures were $210.9 million, suggesting reinvestment needs. The negative net income highlights margin pressures in its core operations.
The company's earnings power is constrained by its net loss, though operating cash flow remains positive. Capital efficiency is under scrutiny given the high capital expenditures relative to cash flow. The negative EPS suggests limited earnings generation, likely due to cost inflation and competitive pricing in the healthcare logistics sector.
Owens & Minor's balance sheet shows $49.4 million in cash and equivalents against $2.14 billion in total debt, indicating a leveraged position. The high debt load raises concerns about financial flexibility, though the company's operating cash flow provides some liquidity. The absence of dividends aligns with its focus on debt management and operational stability.
Growth trends are muted given the net loss, though revenue remains substantial. The company does not pay dividends, prioritizing debt reduction and operational investments. Future growth may depend on margin improvements and strategic initiatives in supply chain optimization.
The market likely views Owens & Minor cautiously due to its profitability challenges and high leverage. Valuation metrics would reflect its earnings deficit, though its revenue base and industry position may support long-term potential if operational improvements materialize.
Owens & Minor's strategic advantages include its extensive distribution network and healthcare sector expertise. The outlook hinges on cost management and leveraging technology to enhance margins. Regulatory and competitive pressures remain key risks, but the company's entrenched market position provides a foundation for recovery.
Company filings (10-K), financial statements
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |